Nadia Habel

Zinc chelation: a metallothionein 2A’s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance

Nadia Habel, Zahia Hamidouche, Isabelle Girault et al. · Cell Death and Disease · 2013 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma

Nausicaa Malissen, Nicolas Macagno, Samuel Granjeaud et al. · OncoImmunology · 2019 · 55 citations · Full text

Medicine, Bioinformatics, Oncology +17

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells

Nadia Habel, Najla El Hachem, Frédéric Soysouvanh et al. · Cell Death and Differentiation · 2021 · 34 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process

Nadia Habel, Bojana Stefanovska, Dimitri Carène et al. · BMC Cancer · 2019 · 32 citations · Full text

Medicine, Cell Biology, Oncology +17

Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells

Najla El Hachem, Nadia Habel, Tanesha Naiken et al. · Cell Death and Differentiation · 2018 · 29 citations · Full text

Medicine, Cell Biology, Oncology +14